Cargando…
Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023938/ https://www.ncbi.nlm.nih.gov/pubmed/36942129 http://dx.doi.org/10.1016/j.jtocrr.2023.100492 |
| _version_ | 1784908996256202752 |
|---|---|
| author | Yatabe, Yasushi |
| author_facet | Yatabe, Yasushi |
| author_sort | Yatabe, Yasushi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10023938 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100239382023-03-19 Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests” Yatabe, Yasushi JTO Clin Res Rep Commentary Elsevier 2023-02-24 /pmc/articles/PMC10023938/ /pubmed/36942129 http://dx.doi.org/10.1016/j.jtocrr.2023.100492 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Yatabe, Yasushi Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests” |
| title | Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests” |
| title_full | Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests” |
| title_fullStr | Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests” |
| title_full_unstemmed | Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests” |
| title_short | Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests” |
| title_sort | comments on the article by miura et al.: “comparable clinical benefit between different subsets selected by pd-l1 22c3 and sp142 tests” |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023938/ https://www.ncbi.nlm.nih.gov/pubmed/36942129 http://dx.doi.org/10.1016/j.jtocrr.2023.100492 |
| work_keys_str_mv | AT yatabeyasushi commentsonthearticlebymiuraetalcomparableclinicalbenefitbetweendifferentsubsetsselectedbypdl122c3andsp142tests |